These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 3728533)

  • 1. Have the new beta-lactams rendered the aminoglycosides obsolete for the treatment of serious nosocomial infections?
    Moellering RC
    Am J Med; 1986 Jun; 80(6B):44-7. PubMed ID: 3728533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Future trends in aminoglycoside therapy.
    Levin S; Karakusis PH
    Am J Med; 1986 Jun; 80(6B):190-4. PubMed ID: 3728529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nosocomial infections due to gram-negative bacilli in compromised hosts: considerations for prevention and therapy.
    Klastersky J
    Rev Infect Dis; 1985; 7 Suppl 4():S552-8. PubMed ID: 3909312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of aminoglycosides in face of introduction of new beta-lactam antibiotics in treatment of nosocomial infection.
    McGowan JE; McClellan DB; Irwin PS
    Infect Control; 1983; 4(6):440-3. PubMed ID: 6558023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there a role for monotherapy with beta-lactam antibiotics in the initial empirical management of febrile neutropenic cancer patients?
    Hathorn JW; Pizzo PA
    J Antimicrob Chemother; 1986 Mar; 17 Suppl A():41-54. PubMed ID: 3519563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seminar on antibiotics V, aminoglycosidic aminocyclitols.
    Rhoades ER
    J Okla State Med Assoc; 1980 Dec; 73(12):409-12. PubMed ID: 7463190
    [No Abstract]   [Full Text] [Related]  

  • 7. New studies in the field of aminoglycosidic aminocyclitol antibiotics.
    Arcamone F; Bertazzoli C; Buogo A; Cassinelli G; Vigevani A
    Panminerva Med; 1974; 16(1-2):9-24. PubMed ID: 4449644
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibiotics in the second half of the 1980s. Areas of future development and the effect of new agents on aminoglycoside use.
    Neu HC
    Am J Med; 1986 Jun; 80(6B):195-203. PubMed ID: 3460336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preventive and therapeutic application possibilities of newer antibiotics (author's transl)].
    Marget W
    MMW Munch Med Wochenschr; 1979 Sep; 121(36):1133-6. PubMed ID: 114782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical application of the newer beta-lactam antibiotics.
    Turck M
    J Antimicrob Chemother; 1988 Jul; 22 Suppl A():45-62. PubMed ID: 3062004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cephalosporins currently in early clinical trials for the treatment of bacterial infections.
    Long TE; Williams JT
    Expert Opin Investig Drugs; 2014 Oct; 23(10):1375-87. PubMed ID: 24956017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminoglycosides: current role in antimicrobial therapy.
    Cunha BA
    Pharmacotherapy; 1988; 8(6):334-50. PubMed ID: 3146747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cephalosporin therapeutics for intensive care infections.
    Salacata A; Chow JW
    New Horiz; 1993 May; 1(2):181-6. PubMed ID: 7922401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative infection in urologic surgery.
    Ward TT
    Urology; 1985 Nov; 26(5 Suppl):6-10. PubMed ID: 3904138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Activity of cefepime compared with other antibiotics against major hospital bacterial pathogens].
    Hryniewicz W; Skoczyńska A; Szczypa K
    Pol Merkur Lekarski; 2001 Feb; 10(56):80-2. PubMed ID: 11320582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emergence of bacterial resistance and its influence on empiric therapy.
    Neu HC
    Rev Infect Dis; 1983; 5 Suppl 1():S9-20. PubMed ID: 6342103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New therapeutic approaches to hospital-acquired pneumonia.
    Pennington JE
    Semin Respir Infect; 1987 Mar; 2(1):67-73. PubMed ID: 3321267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminoglycoside resistance: a worldwide perspective.
    Young LS; Hindler J
    Am J Med; 1986 Jun; 80(6B):15-21. PubMed ID: 3089000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Selection of resistant variants by broad spectrum beta-lactam antibiotics: to what extent is there cross resistance between imipenem and other beta-lactam antibiotics?].
    Kahan F; Kropp H
    Immun Infekt; 1986 Nov; 14(6):232-5. PubMed ID: 3100429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic utilization: is there an effect on antimicrobial resistance?
    Patterson JE
    Chest; 2001 Feb; 119(2 Suppl):426S-30S. PubMed ID: 11171780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.